MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Prodromal Parkinson’s Disease in Agent Orange Exposed US Vietnam Veterans

    E. Uc, C. Weber, M. Lenz, J. Dawson (Iowa City, USA)

    Objective: 1-Comparing the risk of prodromal PD between AO exposed veterans (AOEV) and non-AO exposed veterans without PD (Controls) in a Veterans Affairs (VA) hospital…
  • 2025 International Congress

    Multidisciplinary Approaches to Palliative Care in Late-Stage Parkinson’s Disease: A Review of Educational Tools and Frameworks

    M. Farghaly, H. Khabiry, O. Sabry, A. Nagah, O. Awadalla, M. Elsayed (Giza, Egypt)

    Objective: To evaluate multidisciplinary approaches to palliative care in late-stage Parkinson’s disease (PD) and assess the effectiveness of educational tools and frameworks in improving patient…
  • 2025 International Congress

    Family History of Parkinson’s Disease in Patients with Essential Tremor and in Patients with Parkinson’s Disease and Its Association with Different Phenotypes.

    R. Sanjinez, J. Bestoso (Buenos Aires, Argentina)

    Objective: To clinically and phenotypically describe essential tremor (ET) and parkinson's disease (PD) patients and compare their familial histories in first- and second-degree relatives.. Background:…
  • 2025 International Congress

    Risk factors in a population with high prevalence of Parkinson’s disease in Chile

    ME. Contreras Pinto, U. Hernandez Villarroel, N. Angel, F. Pancetti Vaccari, B. Soto, M. Ramirez, M. Vera Amoroso, J. Otero Olmos, G. Oneto Diaz, C. Morales (la serena, Chile)

    Objective: The aim of this study was to investigate the frequency of environmental risk factors, comorbidities and family history in a population with Pakinson disease…
  • 2025 International Congress

    Perceived Versus Actual Performance During Dual-Task Walking: Insights from Parkinson’s Disease

    H. Johansson, B. Leavy (Stockholm, Sweden)

    Objective: To explore the concordance between perceived difficulty and focus, to actual performance during a dual-task (DT) two-minute walk test (2MWT) in people with Parkinson’s…
  • 2025 International Congress

    Association Between Depression and Sleep Disorders in Parkinson’s Disease

    J. Jiang, W. Wu, M. Mao (Suzhou, China)

    Objective: To investigate the clinical characteristics of depression in Parkinson’s disease (PD) and its correlation with sleep disorders. Background: PD is the second most common…
  • 2025 International Congress

    Neuronal DJ-1 regulates microglia activation via ADAM10-mediated CX3CL1 secretion

    A. Zhao, Y. Jiao, J. Liu, Y. Li (shanghai, China)

    Objective: DJ-1, also known as Parkinson's disease protein 7 (PARK7), is a multifunctional protein that is important in regulating oxidative stress and neuroprotection. Background: The…
  • 2025 International Congress

    Longitudinal Brain Morphometric Trajectories Across Parkinson Disease Clinical Subtypes

    A. Eid, S. Grossen, A. Tanenbaum, J. Hood, H. Hwang, T. Cash, C. Lessov-Schlaggar, J. Jackson, P. Kotzbauer, J. Perlmutter, M. Campbell (Saint Louis, USA)

    Objective: To investigate longitudinal brain morphometric trajectories across Parkinson disease (PD) clinical subtypes Background: We developed a PD multi-domain classification based on motor and non-motor…
  • 2025 International Congress

    Contribution of Dopamine Depletion, Cerebral Perfusion, and Cognition to Gait Dysfunction in Parkinson’s Disease

    HK. Na, CW. Park, Y. Sun, JH. Lee, YY. Choi, SJ. Chung, YH. Sohn, CH. Lyoo, PH. Lee (Seodaemun-gu, Republic of Korea)

    Objective: To explore the potential contribution of dopamine loss, perfusion deficit, and cognition to spatiotemporal gait parameters in patients with Parkinson's disease (PD). Background: Gait…
  • 2025 International Congress

    Comparison of Microglial PET Imaging in Parkinson’s Disease, RBD, and Controls with a CSF1R and TSPO Ligand.

    K. Mills, I. Cheong, Y. Du, J. Coughlin, A. Horti, C. Motley, R. Dannals, W. Lesniak, T. Dawson, M. Pomper (Baltimore, USA)

    Objective: To compare regional binding patterns of microglial PET radioligands: [11C]DPA-713, a TSPO ligand, and [11C]CPPC1, a CSF1R ligand  in people with Parkinson’s disease (PD).…
  • « Previous Page
  • 1
  • …
  • 120
  • 121
  • 122
  • 123
  • 124
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley